Sarah Colombani, a BIM graduate, launches OcciCal Therapeutics
Sarah Colombani, research engineer at the PhyMedExp, is the project leader for OcciCal Therapeutics, a spin-off founded by five co-founders fromInserm, the CNRS , and theUniversity of Montpellier. A winner of the Booster Innovation Montpellier (BIM) award since December, the company is developing a treatment designed to correct a common respiratory dysfunction in hospital settings.
Read the full article: Sarah Colombani, BIM Award Winner, Launches OcciCal Therapeutics
